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Background: The aim of this retrospective study is to investigate the therapeutic benefits and the bleeding risks of
venovenous extracorporeal life support (VV-ECLS) when used for adult posttraumatic respiratory distress syndrome
(posttraumatic ARDS).
Materials and methods: Twenty adult trauma patients (median age: 38 years, median injury severity score: 35)
treated with VV-ECLS in a level I trauma center between January 2004 and June 2013 were enrolled in this study.
The indication of VV-ECLS for posttraumatic ARDS was refractory hypoxemia (PaO2/FiO2 ratio ≤ 70 mmHg) under
advanced mechanical ventilation. To minimize potential complications, a protocol-guided VV-ECLS was adopted.
Results: Sixteen patients were weaned off VV-ECLS, and of these patients fourteen survived. Medians of the
trauma-to-ECLS time, the pre-ECLS mechanical ventilation, and the ECLS duration in all patients were 64, 45,
and 144 hours respectively. The median PaO2/FiO2 ratio was improved significantly soon after VV-ECLS, from
56 to 106 mmHg (p < 0.001). However, seven major hemorrhages occurred during VV-ECLS, of which three
were lethal. The multivariate analysis revealed that the occurrence of major hemorrhages during VV-ECLS was
independently related to the trauma-to-ECLS time < 24 hours (OR: 20; p = 0.02; 95% CI: 2–239; c-index: 0.81).
Conclusions: Despite an effective respiratory support, VV-ECLS should be cautiously administered to patients
who develop advanced ARDS soon after major trauma.
Keywords: Extracorporeal life support, Extracorporeal membrane oxygenation, Posttraumatic acute respiratory
distress syndrome, Blunt chest trauma, Heparin-minimized strategyIntroduction
Acute respiratory distress syndrome (ARDS) is a potentially
lethal problem in trauma patients [1,2]. Based on the Berlin
definition [3], the typical presentation of posttraumatic
ARDS is a hypoxemic status [an arterial oxygen tension
(PaO2)/fraction of inspired oxygen (FiO2) ratio ≤ 300 mmHg
with a positive end-expiratory pressure (PEEP) ≥ 5 cmH2O]
that is accompanied with bilateral pulmonary opacities, and
occurs shortly after trauma. The common predisposing* Correspondence: david3627@gmail.com
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unless otherwise stated.factors of posttraumatic ARDS are blunt thoracic injuries,
traumatic shock requiring massive blood transfusion, and
an injury severity score (ISS) ≥ 25 [2]. Similar to ARDS
caused by nontraumatic etiologies, posttraumatic ARDS is
primarily treated with mechanical ventilation. To reduce
the injurious effects of cyclical inflation and deflation on
the already injured lungs during positive pressure ventila-
tion, lung-protective ventilation is preferred among ARDS
patients, using low tidal-volumes (≤6 mL/kg/min) and op-
timal PEEPs to achieve an inspiratory plateau pressure
(Pplt) ≤ 30 cmH2O [4,5]. However increases in FiO2, PEEP,
and Pplt may be unavoidable when an acceptable arterial
oxygenation cannot be maintained. The hyperinflated-
hyperoxic ventilation may exacerbate pulmonary shunting
and induce a repeated mechanical-biological trauma [6].
This ventilator-induced lung injury may initiate a vicious. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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100 mmHg) with multiple organ dysfunctions [7]. Veno-
venous extracorporeal life support (VV-ECLS) may break
this vicious cycle by conducting a prepulmonary blood gas
exchange to share the workload with native lung, which
enables physicians to continue lung-protective ventilation
[8]. Nevertheless, because of its inherent thrombogenicity
owing to the blood-surface interaction [9], VV-ECLS re-
quires systemic heparinization and involves a 40% risk of
hemorrhage at intracranial, surgical, and cannulation sites
[10]. This risk may increase when VV-ECLS is adminis-
trated to patients who have just sustained major trauma
and damage-control interventions. These patients tend
to have the trauma-induced coagulopathy (TIC) [11] and
may be vulnerable to heparinization. To evaluate the
therapeutic benefits and bleeding risks of VV-ECLS when
used for posttraumatic ARDS, nine years of experience
with this therapy was reviewed.
Materials and methods
Study population
From January 2004 to June 2013, a total of 561 patients re-
ceived ECLS for hemodynamic (venoarterial mode; n =
437) or pulmonary (VV mode; n = 124) support at Chang
Gung Memorial Hospital. Among the 124 patients, 20
adults had posttraumatic ARDS and were enrolled in this
retrospective study. The institutional review board of
the hospital approved the protocol (CGMF IRB no.
102-4437B) and waived the necessity of individual pa-
tient consent.
Therapeutic protocol: conventional mechanical ventilation
The definition of posttraumatic ARDS was based on the
Berlin definition [3]. Conventional mechanical ventila-
tion was used as the primary respiratory support for
posttraumatic ARDS and a lung-protective strategy was
adopted under paralytic sedation. The protocol of con-
ventional mechanical ventilation for posttraumatic
ARDS was demonstrated in our previous report [12] and
showed in Additional file 1. When conventional mechan-
ical ventilation alone was thought insufficient for an ad-
equate arterial oxygenation (often a PaO2/FiO2 ratio <
70 mmHg with a FiO2 ≥ 0.8), VV-ECLS was administered.
The exclusion criteria of VV-ECLS were (1) an uncon-
trolled hemorrhagic shock; (2) an identified acute heart
failure; or (3) a severe traumatic brain injury. A whole
body computed tomography was suggested to all candi-
dates to exclude undetected internal hemorrhages before
the administration of VV-ECLS.
Implantation of VV-ECLS
As reported previously [13], we used the Capiox emer-
gent bypass system (Terumo Inc., Tokyo, Japan) with a
heparin-coated inner surface as our ECLS device. Sincea double lumen catheter was not available during the
period of study, two wire-wound polyurethane vascular
cannulae (DLP Medtronic, Minneapolis, MN, USA; in-
flow: 19–23 French, outflow: 17–21 French) were used to
established the femoral (in)-jugular (out) VV-ECLS via
percutaneous cannulation. The ECLS gas flow rate was
initially set high (10 L/min, pure oxygen), and the blood
pump speed was gradually increased to achieve a pulse
oximetry-detected oxyhemoglobin saturation (SpO2) ≥
90%. If necessary, a modest volume replacement (prefera-
bly packed red blood cell) was used to improve an un-
steady ECLS blood flow. The positions of the cannula tips
were confirmed with a chest-abdominal radiograph in
order to prevent a substantial recirculation.
Therapeutic Protocol of VV-ECLS in posttraumatic ARDS
Figure 1 illustrates our VV-ECLS protocol for posttrau-
matic ARDS. Anticoagulation, oxygenation, and ventila-
tion were three highlighted points. Before implantation,
the ECLS specialists must evaluate the risks and benefits
of administering a fully heparinized (heparin-titrated)
VV-ECLS to the trauma patient. Based on our experience
of postcardiotomy ECLS [14], we routinely administer the
heparin-minimized ECLS to patients who require ECLS
within 24 hours after major surgeries or trauma [15], since
these patients are at high risk for consumption coagulopa-
thies. TIC is a consumption coagulopathy specific to
trauma patients, and is defined as a hypocoagulable state
[prothrombin time (PT)- international normalized ratio
(INR) ≥ 1.2 or the activated partial thromboplastin time
(aPTT) ≥ 35 seconds] presented soon after trauma [16,17].
The active clotting time (ACT) and aPTT were checked
as needed, at least every 6 hour in the first day of VV-
ECLS. In heparin-titrated ECLS, the therapeutic range of
the ACT/aPTT value was 160–180/40–55 seconds, and
heparin was administered intravenously when the aPTT
value dropped below 40 seconds. Patients on the heparin-
minimized ECLS received no exogenous heparinization.
The heparin-minimized ECLS maintained a high blood
flow rate (>3 L/min) and was switched to the heparin-
titrated mode after 48 hours to reduce the possibility of
thromboembolism. To achieve acceptable oxygenation
and to reduce the bleeding risk, hemaglobin and platelet
count were also checked daily to maintain a level more
than 10 g/dL and 80 billion/L, respectively. Coagulation
factor transfusion was seldom needed in patients without
hemorrhage. In patients with hemorrhages, withholding
heparin plus blood transfusion (RBC: plasma: platelet
about 1:1:3) was the first step to achieve hemostasis on
ECLS. Endoscopic, angiographic or surgical hemostasis was
launched with low threshold once the conservative treat-
ment failed or was impossible to stablize the hemorrhage.
When an obvious anisocoria (a diameter difference >
2 mm) was detected, a brain computed tomography was
Figure 1 The therapeutic protocol of venovenous extracorporeal life support in patients with posttraumatic acute respiratory
distress syndrome. ACT: Active clotting time. aPTT: Activated partial thromboplastin time. PEEP: Positive end-expiratory pressure. SpO2:
Pulse oximetry-detected oxyhemoglobin saturation. PaO2: Arterial oxygen tension. PaCO2: Arterial carbon dioxide tension. MAP: Mean arterial
pressure. Hb: Hemoglobin. FiO2: The fraction of inspired oxygen. TV3: Tidal volume. Pplt: Inspiratory plateau pressure.
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VV-ECLS was withdrawn (or rapidly weaned) after
obtaining the family’s permission when a major ICH
was identified. The choice whether to perform a sur-
gical decompression depended on the opinion of the
consulting neurosurgeon.
The adequacy of oxygenation during VV-ECLS was
checked by repeated arterial blood gas samplings, at
least every 6 hours during the first day. With an im-
provement of SpO2, the lung-protective ventilation was
continued with a decreased FiO2, respiratory rate, and
Pplt. However attempts to step-down the FiO2 may be
hindered by an unsatisfactory SpO2 level in spite of a
well-functioning VV-ECLS. A substantial recirculation of
the outflow (oxygenated) blood of VV-ECLS was often
found in this scenario and needed to be corrected
quickly [18]. Figure 1 also outlines common methods
of reducing the recirculation during VV-ECLS. Afteroptimizing the oxygenation, it was critical to remove
the excessive lung water with diuretics or continuous
venovenous hemofiltration in order to improve the pul-
monary compliance [19]. Weaning from the ECLS was
tried once significant pulmonary improvements were
shown. The pump flow was tapered to 2.0 L/min then the
FiO2 of the ECLS gas flow was turned to 0.21. Decannula-
tion was performed after 4 to 6 hours if the patient
remained stable. The weaning process would be stopped if
(1) hemodynamic instability, or (2) a PaO2/FiO2 ratio <
100 mmHg or PaCO2 ≥ 60 mmHg under lung protective
ventilation with a maximal FiO2 of 0.6.
Statistical analysis
Statistical analyses were performed using SPSS for Windows
(Version 15.0, SPSS, Inc., IL, USA). Because the dataset
was small, nonparametric methods including the Mann–
Whitney U or Wilcoxon signed ranks tests was used to
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paired continuous variables. The Chi-square or Fisher’s
exact test was used to compare the categorical variables.
The level of statistical significance was set at p < 0 .05.Table 1 Summary of the characteristics of trauma, types of da
No Age
(year)




1 53 Car-pedestriant accident 20 4 No
2 29 Motorbike accident 17 6 No
3 33 Motorbike accident 29 5 Thoracotomy: RML-RLL
4 38 Motorbike accident 50 8 No
5 59 Car accident 75 9 Pericardiocentesis and su
to release cardiac tampo





41 14 TAE for retroperitoneal h
fixation of pelvic fracture
8 43 Motorbike accident 29 4 No
9 20 Motorbike accident 75 21 TAE for grade 4 hepatic
Laparotomy: Ligation of
right portal vein with per
10 57 Car accident 75 49 TAE for retroperitoneal h
of pelvic fracture.
Laparotomy: Resect term
with end-ileostomy for b
11 37 Accidental fall with chest
penetrating injury
22 74 Laparotomy: Repair gast
perforation, repair spleen
12 61 Motorbike accident 43 91 Laparotomy: Repair sma
13 32 Motorbike accident 29 126 Internal fixation of right p
14 28 Car accident 43 143 TAE for grade 3 hepatic
Laparotomy: Repair mes
15 72 Motorbike accident 18 227 Thoracoscopy for empy
16 56 Motorbike accident 10 150 No
17 25 Trunk-pedestriant
accident








19 27 Compression injury 25 40 Laparotomy: Cystorrhap
20 58 Accidental fall 17 310 TAE for grade 4 renal lac
ECLS: Extracorporeal life support.
MV hour: Mechanical ventilation hour before and extended to ECLS without interru
CA: Cardiac arrest. RML: Right middle lobe of lung, RLL: Right lower lobe of lung.Continuous variables with a p < 0.05 were dichotomized
on the basis of cut-off values [14]. The cut-off values were
determined by the receiver operating characteristic curve















L/RLL lacerations 14 Withdrawn-and-dead
(40)
right hepatic artery with perihepatic
emorrhage, external 16 Survived (222)
21 Survived (77)
laceration. 23 Dead-on-ECLS (24)
right hepatic artery and
ihepatic packing
emorrhage, external fixation 52 Dead-on-ECLS (423)





ll bowel perforation 100 Survived (143)
roximal femoral fracture 138 Dead-on-ECLS (1030)
laceration 175 Survived (94)
ocolonic laceration
ema evacuation 248 Dead-on-ECLS (111)
295 Survived (517)
laceration 384 Survived (456)
bilobectomy and
laceration 574 Weaned-but-Dead (352)
nt bile leak and
ng aortic replacement
hy 115 Survived (161)
eration 334 Survived (169)
ption. TAE: Transcatheter arterial embolization.
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identify independent predictors of in-hospital mortality
and occurrence of major hemorrhages.
Results
Demographics
Table 1 summarizes the trauma characteristics, pre-
ECLS managements, and outcomes of the twenty pa-
tients. A combination of high-grade thoracoabdominal
injuries were common and resulted in a high median ISS
(35; IQR: 21–50). The median durations of the pre-
ECLS mechanical ventilation and the trauma-to-ECLS
time were 45 (IQR: 8–148) hours and 64 (IQR: 12–230)
hours, respectively. Fifteen patients received damage-
control interventions, including thoracotomy (including
subxiphoid incision; n = 7), laparotomy (n = 7), or trans-
catheter arterial embolization (n = 7) before VV-ECLS.
Four patients were diagnosed with minor intracranial






Age (years) 41 (29–57) 30 (22–61) 0.35
Injury severity score 29 (19–43) 63 (26–75) 0.09
Pre-ECLS CPR (n) 1 3 0.06
Pre-ECLS ICH (n) 2 2 0.55
Trauma-to-ECLS hour 49 (10–205) 95 (21–329) 0.35
Trauma-to-ECLS < 24 hours (n) 2 7 0.64
Pre-ECLS intubation hour 27 (6–145) 88 (18–187) 0.31
Pre-ECLS RBC transfusion† (u) 1 (0–4) 10 (1–18) 0.34
Pre-ECLS platelet transfusion (u) 0 6 (0–39) 0.1
Pre-ECLS plasma transfusion‡ (u) 5 (3–16) 11 (0–17) 0.18
Pre-ECLS TIC 9 6 0.26
Heparin-minimized ECLS (n) 7 4 0.64
ECLS pump flow (L/min) 4 (3.6-4.6) 3.7 (3.4-4) 0.27
1st day RBC transfusion† (u) 1 (1–10) 7 (3–13) 0.16
1st day Platelet transfusion (u) 0 (0–24) 12 (12–24) 1.0
1st day Plasma transfusion‡ (u) 11 (5–22) 10 (0–24) 0.26
CVVH on ECLS (n) 3 4 0.12
Hemorrhagic complications (n) 4 3 0.61
Weaning-off ECLS (n) 14 2 0.003
ECLS hour 144 (74–196) 232 (36–575) 0.9
Post-ECLS intubation hour 231 (61–476) - -
Tracheostomy (n) 7 1 0.33
Hospital days 69 (27–81) 32 (4–46) 0.04*
Numerical variable is presented as median and interquartile range (IQR).
ECLS: Extracorporeal life support. CPR: Cardiopulmonary resuscitation. ICH: Intracra
the initiation of ECLS. †RBC transfusion includes the amount of whole blood and pa
blood, frozen fresh plasma and cryoprecipitate. TIC: Trauma induced coagulopathy
hemofiltration. *p < 0.05.and 15) before VV-ECLS. Sixteen patients were weaned
off VV-ECLS and fourteen survived. The six nonsurvivors
died of sepsis (n = 3) or hemorrhagic complications dur-
ing ECLS (n = 3). Table 2 lists the results of univariate
comparisons of clinical parameters between different pa-
tient groups. Despite there being no independent risk fac-
tor of in-hospital mortality identified, a trauma-to-ECLS
time ≤ 15 hours [Sensitivity (Sn): 71%; Specificity (Sp): 92%;
Positive Predictive Value (PPV): 83%; Negative Predictive
Value (NPV): 86%; area under ROC curve (AUROC): 0.82;
p = 0.02] was found to be the independent predictor of
hemorrhage during VV-ECLS [odd ratio (OR): 30, p = 0.01,
95% confidence intervals (CI): 2–441]. For practical pur-
poses, we also tested the predictive power of a trauma-
to-ECLS time ≤ 24 hours. Acceptable predictive power
was also obtained in this cut-off point (Sn: 86%; Sp:
77%; PPV: 67%, NPV: 91%, AUROC: 0.81; p = 0.02). The
OR, p value, and 95% CI at this point were 20, 0.02, and
2–239, respectively.Patient with hemorrhagic
complication (n = 7)
Patient without hemorrhage
complications (n = 13)
p
33 (23–53) 43 (28–58) 0.49
29 (18–75) 41 (24–47) 1.0
2 2 0.59
2 2 0.59
10 (7–23) 115 (37–315) 0.008*
6 3 0.02*
8 (5–21) 91 (27–162) 0.04*
6 (3–17) 1 (0–3) 0.05*
0 (0–18) 0 0.58
5 (3–16) 2 (0–6) 0.05*
6 9 0.61
7 4 0.005*
4.1 (3.3-4.3) 3.6 (3.5-4.6) 0.7
10 (3–14) 1 (1–6) 0.007*
24 (12–24) 0 (0–12) 0.03*
11 (5–22) 0 (0–7) 0.05*
1 6 0.33
- - -
* 5 11 0.59
69 (40–145) 169 (86–440) 0.02*
72 (0–363) 111 (23–427) 0.7
2 6 0.64
45 (5–76) 45 (27–78) 0.49
nial hemorrhage. Trauma-to-ECLS hour: The time interval between trauma to
cked red cell concentrate. ‡Plasma transfusion includes the amount of whole
(INR > 1.3 or aPTT > 35 seconds). CVVH: Continuous venovenous





p Patient with hemorrhagic
complication (n = 7)
Patient without hemorrhage
complications (n = 13)
p
Pre-ECLS data
PaO2 (mmHg) 56 (48–73) 55 (42–67) 0.55 53 (42–66) 58 (49–69) 0.59
PaO2/FiO2 ratio (mmHg) 56 (48–73) 57 (42–68) 0.66 53 (42–66) 58 (49–70) 0.7
PaCO2 (mmHg) 61 (47–89) 52 (41–76) 0.64 49 (40–78) 52 (49–91) 1.0
Hemoglobin (g/dL) 11 (10–13) 9 (8–11) 0.06 10 (9–15) 11 (9–12) 0.64
Platelet count (×109/L) 164 (90–193) 88 (51–34) 0.11 172 (107–183) 115 (67–193) 0.76
INR of Prothrombin Time > 1.2 7 6 0.05* 5 8 1.0
aPTT > 35 (seconds) 7 3 1.0 5 5 0.35
Data collected on ECLS at1 hour
PaO2/FiO2 ratio (mmHg) 108 (65–103) 103 (71–151) 0.84 99 (166–146) 110 (74–171) 0.54
PaCO2 (mmHg) 37 (30–46) 39 (31–45) 0.46 42 (35–44) 35 (27–48) 1.0
Hemoglobin g/dL) 10 (9–11) 10 (9–14) 0.72 10 (8–12) 10 (9–11) 0.76
Platelet count (×109/L) 98 (65–153) 100 (45–134) 0.72 99 (31–142) 100 (64–160) 0.54
INR of Prothrombin Time > 12† 2 1 1.0 3 0 0.03*
aPTT > 120† (seconds) 10 6 0.27 6 10 1.0
at24 hour
PaO2/FiO2 ratio (mmHg) 190 (100–246) 93 (86–262) 0.44 98 (86–238) 180 (96–252) 0.59
Hemoglobin (g/dL) 10 (9–11) 10 (9–12) 0.6 10 (8.8-12) 10 (9–11) 0.82
Platelet count (×109/L) 99 (63–139) 76 (62–92) 0.18 75 (62–93) 96 (73–131) 0.18
Before ECLS weaning
PaO2/FiO2 ratio (mmHg) 261 (186–338) - - 229 (135–256) 288 (178–343) 0.18
Numerical variable is presented as median and interquartile range (IQR).
ECLS: Extracorporeal life support. PaO2/FiO2 ratio: The arterial oxygen tension (PaO2) divided by the fraction of inspired oxygen (FiO2). INR: International
normalized ratio. aPTT: Activated partial thromboplastin time. TIC: Trauma induced coagulopathy (INR > 1.3 or aPTT > > 35). *p < 0.05. †The maximum of the
detectable values.
Wu et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2014, 22:56 Page 6 of 9
http://www.sjtrem.com/content/22/1/56Improvements of arterial gas exchange
A series of changes in PaO2/FiO2 ratio during VV-ECLS
between different patient groups was demonstrated in
Table 3. An improved oxygenation was showed in all pa-
tients soon after the administration of VV-ECLS. After
testing by the Wilcoxon signed ranks test, the increase of
PaO2/FiO2 ratio was significant in survivors (p = 0.004),
non-survivors (p = 0.03), patients with hemorrhagesTable 4 Management of Hemorrhagic Complications on veno
Case Clinical presentations (Hours after ECLS initiation) Hemo
1 Hemorrhaging from the open fracture wound of sternum (2) Fractu
2 Anisocoria (61) Multip
3 Abdominal compartment syndrome (IAP * > 30 cm H2O) (12) The c
4 Anisocoria (71) Intrav
6 Hemorrhaging from the decompressive laparotomy (12) The p
Anisocoria (40) Multip
9 Hemorrhaging from the decompressive laparotomy (4) The p
15 Hemorrhaging from the chest tube (15) The d
*IAP: Intra-abdominal pressure.(p = 0.003), and patients without hemorrhages (p = 0.005).
However, only the survivors showed a continuous increase
in PaO2/FiO2 ratio in the first day of VV-ECLS (p = 0.01).
The Incidence of Hemorrhaging during ECLS
Eleven patients (Cases 1–10 and Case 15 for just receiving
surgery for empyema) fulfilled the criteria and received
heparin-minimized VV-ECLS for 48 hours. Seven patientsvenous extracorporeal life support
rrhagic site Intervention on ECLS (Outcome)
red sternum Sternotomy (Survived)
le intracranial hemorrhages Craniotomy (Survived)
onservatively-treated liver laceration Peritoneal drainage (Survived)
entricular hemorrhage No (Survived)
acked liver laceration Laparotomy (Dead)
le Intracranial hemorrhages.
acked liver laceration No (Dead)
ecorticated lung Thoracotomy (Dead)
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after a median ECLS duration of 12 (4–61) hours. All of
the seven patients received heparin-minimized VV-ECLS
as a prophylactic measure. The clinical presentations and
management of the seven hemorrhagic complications are
summarized in Table 4. A series of changes in coagulation
profiles during VV-ECLS between different patient groups
was also demonstrated in Table 3. To investigate the re-
sponse of the patients’ coagulation system to different
ECLS strategies, aPTT data collected during the first day
of VV-ECLS are presented as box plots in Figure 2.Figure 2 The time courses of the activated partial thromboplastin tim
support. Median with 25th to 75th interquatile range. *The upper limit of dDiscussion
This study aimed to investigate the therapeutic benefits
and the safety of VV-ECLS when used for adult posttrau-
matic ARDS, since the ECLS-associated coagulopathy
may induce severe consequences in trauma patients. As
seen in previous reports [20,21] and the current study,
VV-ECLS is an efficient device to improve the blood gas
exchange and may achieve a survival rate of more than
70% in adult patients with severe posttraumatic ARDS.
The incidence of major hemorrhages during VV-ECLS is
quite low in patients receiving VV-ECLS after several dayse during the first 24 hours of venovenous extracorporeal life
etectable value of aPTT is 120 seconds.
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ARDS [10]. According to a recent study reported by Ried
et al. [20], the incidence of major hemorrhages during
extracorporeal lung support (n = 52; 26 used VV-ECLS) is
only 4% (n = 2) in patients with a median trauma-to-ECLS
time of 4.5 days. However, the therapeutic challenge here
is administering VV-ECLS to patients at high risk for TIC.
Despite being guided by a comprehensive protocol, the
current study still yielded an incidence of major hemor-
rhages of 35% (n = 7) in 20 patients with a median
trauma-to-ECLS time of 64 hours (2.7 days). The median
trauma-to-ECLS time was only 10 hours in the group of
hemorrhage. To explain the high incidence of major hem-
orrhages, we analyzed the changes of blood coagulability
during VV-ECLS in order to evaluate the interaction be-
tween TIC and ECLS-associated coagulopathy. Since there
is little literature information about this issue, the current
report should provide valuable information to ECLS
specialists who attempt to enroll patients that have just
sustained major trauma or damage-control interventions.
As shown in Figure 2, all patients experienced an ex-
tremely hypocoagulable state soon after being connected
to an ECLS circuit. The suppression of blood coagulability
decayed with time and almost disappeared after 12 hours
in most of the patients. This phenomenon seemed to be
compatible with the pharmacodynamics of heparin. Ex-
cept the initial hypocoagulability, all patients showed a
decreased platelet count after 24 hours of ECLS. This
platelet consumption was also found in previous studies
and could be explained by an increased volume of distri-
bution and blood-surface interaction during extracorpor-
eal circulation [9,13]. Therefore we might suggest that the
ECLS-associated coagulopathy was a profound hypocoa-
gulable state induced by heparinization, hemodulition and
platelet consumption [9]. This heparin-induced hypocoa-
gulability may persist for 12 hours in adult patients with a
relatively normal coagulability before VV-ECLS. From this
viewpoint, reducing or even pharmacologically neutraliz-
ing the heparin content at the beginning of VV-ECLS
should be helpful to attenuate the anticoagulant impact of
ECLS.
In regards to the interaction between TIC and ECLS-
associated coagulopathy, we had some indirect findings.
As we were limited by the small number of cases, we
failed to identify the correlation between TIC and the
major hemorrhage during VV-ECLS, but we did find
that the blood coagulability (both the intrinsic and exter-
nal coagulation pathways) and the platelet counts were
more suppressed in the hemorrhage group than in the
non-hemorrhage group at the beginning of ECLS. Pa-
tients in the hemorrhage group also had more blood
transfusions in the day before ECLS. Therefore, we may
assume that these patients have a more severe TIC and
are very sensitive to ECLS-associated coagulopathy, evento the heparin-minimized ECLS. The two coagulopathies
may exert a synergistic effect strongly against blood co-
agulation and cause diffuse hemorrhages from the crushed
solid organs and soft tissues. Despite there might be room
for hemostasis with transfusion therapy alone, a proactive
stance of surgical interventions should be taken toward
major hemorrhages during ECLS. Not only because
hemorrhages may reduce the efficacy of gas exchange on
VV-ECLS by decreasing the pump flow rate and the amount
of hemoglobin [22], but also as the transfusion therapy it-
self may also worsen the existed pulmonary injury.
The limitations of this study are its retrospective de-
sign and the small number of cases involved. Further
prospective and collaborative studies involving large
populations and an integrated protocol of coagulation
measurements (such as the thrombelastogram) are ne-
cessary to optimize the analysis of the therapeutic effects
of VV-ECLS.
Conclusion
VV-ECLS is an effective respiratory support in adult post-
traumatic ARDS. However, the risk of major hemorrhage
during VV-ECLS may be significant in patients who have
just sustained major trauma and have a packed or conser-
vatively treated hemorrhage.
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